NoNO Inc.

Industry · 7 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombe Acute Ischemic Stroke	Phase 2	2024-10-02
Completed	A Phase 1 Study to Evaluate Safety and Tolerability of NoNO-42 in Healthy Adults First-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic Stroke	Phase 1	2022-11-22
Completed	Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombect Stroke, Acute	Phase 3	2020-12-06
Completed	Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke Stroke, Acute	Phase 3	2017-03-01
Withdrawn	Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneu Subarachnoid Hemorrhage, Ruptured Intracranial Aneurysm	Phase 2	2015-11-01
Completed	Field Randomization of Nerinetide (NA-1) Therapy in Early Responders Acute Cerebral Ischemia	Phase 3	2015-03-26
Completed	Evaluating Neuroprotection in Aneurysm Coiling Therapy Stroke	Phase 2	2008-08-01